SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5n4g'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQT_B_ACTB1867_0 (FPRA)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 4	ALA H 40 ARG H 38 GLN H 43 GLU H 46	None	1.11A	1lqtB-5n4gH: undetectable	1lqtB-5n4gH: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQU_B_ACTB1424_0 (FPRA)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 4	ALA H 40 ARG H 38 GLN H 43 GLU H 46	None	1.14A	1lquB-5n4gH: undetectable	1lquB-5n4gH: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TZ8_C_DESC129_1 (TRANSTHYRETIN)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 6	LEU H 126 ALA H 139 SER H 129 SER H 130	None	1.02A	1tz8C-5n4gH: 4.1 1tz8D-5n4gH: undetectable	1tz8C-5n4gH: 21.24 1tz8D-5n4gH: 21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y03_A_5FWA601_1 (BETA-1 ADRENERGIC RECEPTOR)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	VAL H 165 VAL H 184 SER H 182 ASN H 199 ASN H 157	None	1.45A	2y03A-5n4gH: undetectable	2y03A-5n4gH: 18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HGX_A_SALA102_1 (SALICYLATE BIOSYNTHESIS PROTEIN PCHB)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 7	ARG H 98 VAL H 2 TYR H 27 GLN H 1	EDO H 302 (-3.5A) None None None	0.91A	3hgxA-5n4gH: undetectable	3hgxA-5n4gH: 15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HRD_B_NIOB5661_1 (NICOTINATE DEHYDROGENASE LARGE MOLYBDOPTERIN SUBUNIT NICOTINATE DEHYDROGENASE MEDIUM MOLYBDOPTERIN SUBUNIT)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 8	ILE H 51 ALA H 53 THR H 74 ALA H 24	None	0.95A	3hrdA-5n4gH: undetectable 3hrdB-5n4gH: undetectable	3hrdA-5n4gH: 20.00 3hrdB-5n4gH: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3REM_A_SALA301_1 (SALICYLATE BIOSYNTHESIS PROTEIN PCHB)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 8	ARG H 98 VAL H 2 TYR H 27 GLN H 1	EDO H 302 (-3.5A) None None None	0.93A	3remA-5n4gH: undetectable	3remA-5n4gH: 15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3REM_B_SALB301_1 (SALICYLATE BIOSYNTHESIS PROTEIN PCHB)	5n4g	HEAVY CHAIN (Homo sapiens)	4 / 8	ARG H 98 VAL H 2 TYR H 27 GLN H 1	EDO H 302 (-3.5A) None None None	0.96A	3remB-5n4gH: undetectable	3remB-5n4gH: 15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.82A	4qvnH-5n4gH: undetectable 4qvnI-5n4gH: undetectable	4qvnH-5n4gH: 23.64 4qvnI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 10	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.82A	4qvnV-5n4gH: undetectable 4qvnW-5n4gH: undetectable	4qvnV-5n4gH: 23.64 4qvnW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.79A	4qvpH-5n4gH: undetectable 4qvpI-5n4gH: undetectable	4qvpH-5n4gH: 23.64 4qvpI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.80A	4qvpV-5n4gH: undetectable 4qvpW-5n4gH: undetectable	4qvpV-5n4gH: 23.64 4qvpW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.81A	4qvqH-5n4gH: undetectable 4qvqI-5n4gH: undetectable	4qvqH-5n4gH: 23.64 4qvqI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.80A	4qvqV-5n4gH: undetectable 4qvqW-5n4gH: undetectable	4qvqV-5n4gH: 23.64 4qvqW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qvvH-5n4gH: undetectable	4qvvH-5n4gH: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qvvV-5n4gH: undetectable	4qvvV-5n4gH: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qvyH-5n4gH: undetectable	4qvyH-5n4gH: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qvyV-5n4gH: undetectable 4qvyW-5n4gH: undetectable	4qvyV-5n4gH: 23.64 4qvyW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	4qw0H-5n4gH: undetectable 4qw0I-5n4gH: undetectable	4qw0H-5n4gH: 23.64 4qw0I-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	4qw0V-5n4gH: undetectable 4qw0W-5n4gH: undetectable	4qw0V-5n4gH: 23.64 4qw0W-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	4qw1H-5n4gH: undetectable 4qw1I-5n4gH: undetectable	4qw1H-5n4gH: 23.64 4qw1I-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	4qw1V-5n4gH: undetectable 4qw1W-5n4gH: undetectable	4qw1V-5n4gH: 23.64 4qw1W-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qwuH-5n4gH: undetectable 4qwuI-5n4gH: undetectable	4qwuH-5n4gH: 23.64 4qwuI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	4qwuV-5n4gH: undetectable 4qwuW-5n4gH: undetectable	4qwuV-5n4gH: 23.64 4qwuW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZBR_A_ACTA608_0 (SERUM ALBUMIN)	5n4g	HEAVY CHAIN (Homo sapiens)	3 / 3	LYS H 101 ARG H 98 HIS H 32	None EDO H 302 (-3.5A) EDO H 302 (-3.9A)	1.27A	4zbrA-5n4gH: undetectable	4zbrA-5n4gH: 17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.85A	5bxnH-5n4gH: undetectable 5bxnI-5n4gH: undetectable	5bxnH-5n4gH: 23.64 5bxnI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.83A	5cz7V-5n4gH: undetectable 5cz7W-5n4gH: undetectable	5cz7V-5n4gH: 23.64 5cz7W-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.83A	5d0xV-5n4gH: undetectable	5d0xV-5n4gH: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.79A	5l5fH-5n4gH: undetectable 5l5fI-5n4gH: undetectable	5l5fH-5n4gH: 23.64 5l5fI-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.79A	5l5fV-5n4gH: undetectable 5l5fW-5n4gH: undetectable	5l5fV-5n4gH: 23.64 5l5fW-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	5l66H-5n4gH: undetectable 5l66I-5n4gH: undetectable	5l66H-5n4gH: 23.64 5l66I-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5n4g	HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 190 GLY H 136 THR H 137 ALA H 138 THR H 133	None	0.84A	5l66V-5n4gH: undetectable 5l66W-5n4gH: undetectable	5l66V-5n4gH: 23.64 5l66W-5n4gH: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5n4g	HEAVY CHAIN (Homo sapiens)	6 / 12	VAL H 186 THR H 137 LEU H 161 VAL H 165 GLY H 164 VAL H 213	None	1.49A	6a94B-5n4gH: undetectable	6a94B-5n4gH: 19.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1LQT_B_ACTB1867_0","FPRA","5n4g","HEAVY CHAIN","Homo sapiens",4,"ALA H  40;ARG H  38;GLN H  43;GLU H  46","None","1.11A","1lqtB-5n4gH:undetectable","1lqtB-5n4gH:19.00"],["1LQU_B_ACTB1424_0","FPRA","5n4g","HEAVY CHAIN","Homo sapiens",4,"ALA H  40;ARG H  38;GLN H  43;GLU H  46","None","1.14A","1lquB-5n4gH:undetectable","1lquB-5n4gH:19.00"],["1TZ8_C_DESC129_1","TRANSTHYRETIN;TRANSTHYRETIN","5n4g","HEAVY CHAIN","Homo sapiens",4,"LEU H 126;ALA H 139;SER H 129;SER H 130","None","1.02A","1tz8C-5n4gH:4.1;1tz8D-5n4gH:undetectable","1tz8C-5n4gH:21.24;1tz8D-5n4gH:21.24"],["2Y03_A_5FWA601_1","BETA-1 ADRENERGIC RECEPTOR","5n4g","HEAVY CHAIN","Homo sapiens",5,"VAL H 165;VAL H 184;SER H 182;ASN H 199;ASN H 157","None","1.45A","2y03A-5n4gH:undetectable","2y03A-5n4gH:18.00"],["3HGX_A_SALA102_1","SALICYLATE BIOSYNTHESIS PROTEIN PCHB","5n4g","HEAVY CHAIN","Homo sapiens",4,"ARG H  98;VAL H   2;TYR H  27;GLN H   1","EDO H 302 (-3.5A);None;None;None","0.91A","3hgxA-5n4gH:undetectable","3hgxA-5n4gH:15.89"],["3HRD_B_NIOB5661_1","NICOTINATE DEHYDROGENASE LARGE MOLYBDOPTERIN SUBUNIT;NICOTINATE DEHYDROGENASE MEDIUM MOLYBDOPTERIN SUBUNIT","5n4g","HEAVY CHAIN","Homo sapiens",4,"ILE H  51;ALA H  53;THR H  74;ALA H  24","None","0.95A","3hrdA-5n4gH:undetectable;3hrdB-5n4gH:undetectable","3hrdA-5n4gH:20.00;3hrdB-5n4gH:20.93"],["3REM_A_SALA301_1","SALICYLATE BIOSYNTHESIS PROTEIN PCHB","5n4g","HEAVY CHAIN","Homo sapiens",4,"ARG H  98;VAL H   2;TYR H  27;GLN H   1","EDO H 302 (-3.5A);None;None;None","0.93A","3remA-5n4gH:undetectable","3remA-5n4gH:15.12"],["3REM_B_SALB301_1","SALICYLATE BIOSYNTHESIS PROTEIN PCHB","5n4g","HEAVY CHAIN","Homo sapiens",4,"ARG H  98;VAL H   2;TYR H  27;GLN H   1","EDO H 302 (-3.5A);None;None;None","0.96A","3remB-5n4gH:undetectable","3remB-5n4gH:15.12"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.82A","4qvnH-5n4gH:undetectable;4qvnI-5n4gH:undetectable","4qvnH-5n4gH:23.64;4qvnI-5n4gH:20.00"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.82A","4qvnV-5n4gH:undetectable;4qvnW-5n4gH:undetectable","4qvnV-5n4gH:23.64;4qvnW-5n4gH:20.00"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.79A","4qvpH-5n4gH:undetectable;4qvpI-5n4gH:undetectable","4qvpH-5n4gH:23.64;4qvpI-5n4gH:20.00"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.80A","4qvpV-5n4gH:undetectable;4qvpW-5n4gH:undetectable","4qvpV-5n4gH:23.64;4qvpW-5n4gH:20.00"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.81A","4qvqH-5n4gH:undetectable;4qvqI-5n4gH:undetectable","4qvqH-5n4gH:23.64;4qvqI-5n4gH:20.00"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.80A","4qvqV-5n4gH:undetectable;4qvqW-5n4gH:undetectable","4qvqV-5n4gH:23.64;4qvqW-5n4gH:20.00"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qvvH-5n4gH:undetectable","4qvvH-5n4gH:23.64"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qvvV-5n4gH:undetectable","4qvvV-5n4gH:23.64"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qvyH-5n4gH:undetectable","4qvyH-5n4gH:23.64"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qvyV-5n4gH:undetectable;4qvyW-5n4gH:undetectable","4qvyV-5n4gH:23.64;4qvyW-5n4gH:20.00"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","4qw0H-5n4gH:undetectable;4qw0I-5n4gH:undetectable","4qw0H-5n4gH:23.64;4qw0I-5n4gH:20.00"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","4qw0V-5n4gH:undetectable;4qw0W-5n4gH:undetectable","4qw0V-5n4gH:23.64;4qw0W-5n4gH:20.00"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","4qw1H-5n4gH:undetectable;4qw1I-5n4gH:undetectable","4qw1H-5n4gH:23.64;4qw1I-5n4gH:20.00"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","4qw1V-5n4gH:undetectable;4qw1W-5n4gH:undetectable","4qw1V-5n4gH:23.64;4qw1W-5n4gH:20.00"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qwuH-5n4gH:undetectable;4qwuI-5n4gH:undetectable","4qwuH-5n4gH:23.64;4qwuI-5n4gH:20.00"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","4qwuV-5n4gH:undetectable;4qwuW-5n4gH:undetectable","4qwuV-5n4gH:23.64;4qwuW-5n4gH:20.00"],["4ZBR_A_ACTA608_0","SERUM ALBUMIN","5n4g","HEAVY CHAIN","Homo sapiens",3,"LYS H 101;ARG H  98;HIS H  32","None;EDO H 302 (-3.5A);EDO H 302 (-3.9A)","1.27A","4zbrA-5n4gH:undetectable","4zbrA-5n4gH:17.47"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.85A","5bxnH-5n4gH:undetectable;5bxnI-5n4gH:undetectable","5bxnH-5n4gH:23.64;5bxnI-5n4gH:20.00"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.83A","5cz7V-5n4gH:undetectable;5cz7W-5n4gH:undetectable","5cz7V-5n4gH:23.64;5cz7W-5n4gH:20.00"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.83A","5d0xV-5n4gH:undetectable","5d0xV-5n4gH:23.64"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.79A","5l5fH-5n4gH:undetectable;5l5fI-5n4gH:undetectable","5l5fH-5n4gH:23.64;5l5fI-5n4gH:20.00"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.79A","5l5fV-5n4gH:undetectable;5l5fW-5n4gH:undetectable","5l5fV-5n4gH:23.64;5l5fW-5n4gH:20.00"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","5l66H-5n4gH:undetectable;5l66I-5n4gH:undetectable","5l66H-5n4gH:23.64;5l66I-5n4gH:20.00"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5n4g","HEAVY CHAIN","Homo sapiens",5,"SER H 190;GLY H 136;THR H 137;ALA H 138;THR H 133","None","0.84A","5l66V-5n4gH:undetectable;5l66W-5n4gH:undetectable","5l66V-5n4gH:23.64;5l66W-5n4gH:20.00"],["6A94_B_ZOTB3001_0","5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562","5n4g","HEAVY CHAIN","Homo sapiens",6,"VAL H 186;THR H 137;LEU H 161;VAL H 165;GLY H 164;VAL H 213","None","1.49A","6a94B-5n4gH:undetectable","6a94B-5n4gH:19.00"]]